PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v7i6.5567ArticleEvaluating the Efficacy of Fecal Occult Blood Test and Tumor Marker Combined Screening for Colorectal Cancerhttps://artdesignp.com/journal/PAR/7/6/10.26689/par.v7i6.5567YuYuan2023762023-11-07Objective: To analyze the screening effectiveness of combining the fecal occult blood test with tumor marker detection for colorectal cancer. Methods: A total of thirty patients with colorectal cancer and thirty patients with benign colon hyperplasia who received treatment from January 2020 to January 2023 were selected. These patients were assigned to the observation group and the control group, respectively. All patients in both groups underwent both fecal occult blood tests and tumor marker detection. The levels of tumor markers between the two groups were compared, the tumor marker levels in different stages were assessed within the observation group, and the positive detection rates for single detection and combined detection were compared. Results: The levels of various tumor markers in the observation group were significantly higher than those in the control group (P < 0.05). Furthermore, as the Duke stage increased within the observation group, the levels of various tumor markers also increased (P < 0.05). The positive detection rate of the combined test was notably higher than that of single detection (P < 0.05). Conclusion: Combining the fecal occult blood test with tumor marker detection in colorectal cancer screening can significantly improve the overall detection rate.

Huang H, He A, Xu X, et al., 2023, Application of Fecal miRNA-92a Expression and Fecal Occult Blood Test in Joint Diagnosis of Colorectal Cancer. International Journal of Gerontology, 44(5): 591–596.

Chen X, Lin X, 2023, Application of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 199, Carbohydrate Antigen 125 Combined with Fecal Occult Blood Test in Early Screening of Colorectal Cancer. Jilin Medicine, 44(6): 1479–1482.

Zhao D, Qu Z, Sun X, et al., 2022, Analysis of the Value of Single and Combined Detection of Tumor Markers CEA, CA19-9, CA125, and Fecal Occult Blood Test in the Diagnosis of Colorectal Cancer. Chinese Journal of Anorectal Diseases, 42(8): 6–10.

Zhou R, Wang P, Ma M, et al., 2022, Comparison of the Screening Value of Fecal High-Sensitivity Quantitative Immunochemical Test and Qualitative Occult Blood Test for Colorectal Cancer and Advanced Adenoma. Chinese Medical Journal, 102(46): 3667–3672.

Song Z, Fan Z, Zhang Q, et al., 2022, Technical Specifications and Guidance for Screening Colorectal Cancer Using Quantitative Immunoassay Fecal Occult Blood Test. Chinese Journal of Health Management, 16(6): 361–365.

Li Z, Ye H, Chen D, et al., 2020, Clinical Application Value of Fecal Occult Blood Test Combined with Tumor Marker Detection in Colorectal Cancer. Chinese Medical Equipment, 17(7): 101–104.

Zhu Y, Chen X, 2022, Evaluation of the Effectiveness of Fecal Occult Blood Test and SDC2 Gene Methylation Detectionin Colorectal Cancer Screening. Chinese Oncology, 31(9): 723–727.

Gao Y, Kong Y, Dong D, et al., 2023, Comparison of Detection Rates of Risk Score Model, Immunoassay Fecal Occult Blood Test and Their Combined Screening Program in Colorectal Cancer Screening in Xuzhou City. Modern Preventive Medicine, 50(5): 954–960.

Kong Y, Dong D, Chen H, et al., 2022, Comparison of the Application Effects of Colonoscopy, Fecal Occult Blood Test and New Risk Assessment Screening Program in Colorectal Cancer Screening in Xuzhou City. Chinese Journal of Preventive Medicine, 56(8): 1074–1079.

Chen H, Lu M, Liu C, et al., 2020, Comparison of Participation Rates and Influencing Factors of Colonoscopy, Immunoassay Fecal Occult Blood Test and New Risk Assessment Screening Program in Population Colorectal Cancer Screening. Chinese Epidemic Journal of Diseases, 41(10): 1655–1661.

Lu M, Chen H, Liu C, et al., 2020, Evaluation of the Effectiveness of Quantitative Immune Fecal Occult Blood Test in Screening Advanced Colorectal Tumors. Chinese Journal of Epidemiology, 41(12): 2104–2111.

Xu Y, Li Z, Zhu M, 2023, Clinical Value and Correlation Analysis of Blood Tumor Markers and Fecal Occult Blood Results in Patients with Colorectal Cancer. Western Medicine, 35(7): 987–991.